Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial

BACKGROUND: Clarithromycin-containing triple regimen for eradication of Helicobacter pylori is no longer acceptable in Korea due to high clarithromycin resistance. Concomitant therapy or bismuth-containing quadruple therapy is recommended as an alternative regimen. A recent study in Korea has shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Hyun, Bang, Chang Seok, Shin, Woon Geon, Choi, Jae Ho, Soh, Jae Seung, Kang, Ho Suk, Yang, Young Joo, Hong, Ji Taek, Shin, Suk Pyo, Suk, Ki Tae, Lee, Jae Jun, Baik, Gwang Ho, Kim, Dong Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257664/
https://www.ncbi.nlm.nih.gov/pubmed/30431605
http://dx.doi.org/10.1097/MD.0000000000013245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257664/
https://www.ncbi.nlm.nih.gov/pubmed/30431605
http://dx.doi.org/10.1097/MD.0000000000013245

Ejemplares similares